CAS 319924-73-7
:(+/-)-tert-Butyl 6-Chloro-5-hydroxy-3-oxohexanoate
Description:
(+/-)-tert-Butyl 6-Chloro-5-hydroxy-3-oxohexanoate, with the CAS number 319924-73-7, is an organic compound characterized by its ester functional group, which is derived from a carboxylic acid and an alcohol. This compound features a tert-butyl group, contributing to its hydrophobic character, and a chloro substituent that can influence its reactivity and biological activity. The presence of a hydroxy group indicates potential for hydrogen bonding, which may affect its solubility in polar solvents. The keto group (3-oxo) suggests that it may participate in various chemical reactions, including condensation and reduction. The overall structure indicates that it may be used in synthetic organic chemistry, potentially as an intermediate in the synthesis of more complex molecules. Additionally, the presence of stereocenters implies that this compound may exist as enantiomers, which can exhibit different biological activities. Its specific applications and reactivity would depend on the context of its use in chemical synthesis or pharmaceutical development.
Formula:C10H17ClO4
Synonyms:- Rosuvastatin Impurity 97
- Hexanoic acid, 6-chloro-5-hydroxy-3-oxo-, 1,1-dimethylethyl ester
- (+/-)-tert-Butyl 6-Chloro-5-hydroxy-3-oxohexanoate
- (S)-6-chloro-5-hydroxy-3-oxohexanoic acid, 1,1-dimethylethyl ester
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.
(+/-)-tert-Butyl 6-Chloro-5-hydroxy-3-oxohexanoate
CAS:Controlled Product<p>Applications (+/-)-tert-Butyl 6-Chloro-5-hydroxy-3-oxohexanoate is an impurity in the synthesis of Rosuvastatin (R700500), a selective, competitive HMG-CoA reductase inhibitor. Antilipemic.<br>References Watanabe, M., et al.: Bioorg. Med. Chem., 5, 437 (1997), Lee, E., et al.: Clin. Pharmacol. Ther., 78, 330 (2005), Ferdinand, K.C., et al.: Am. J. Cardiol., 97, 229 (2006);<br></p>Formula:C10H17lO4Color and Shape:NeatMolecular weight:236.69
